MDCK-MRP2 - Dkfz

202
Forschungsschwerpunkt C
Krebsrisikofaktoren und Krebsprävention
[21] Snellman, E*; Strozyk, M*; Segerbäck, D*; Klimenko, T*;
Hemminki, K. Effect of the spectral range of a UV lamp on the
production of cyclobutane pyrimidine dimers in human skin in situ.
Photodermatol Photoimmunol Photomed (2003) 19:281-6.
[22] Kumar, R; Angelini, S*; Hemminki, K. Activating BRAF and Nras
mutations in sporadic primary melanoma: an inverse association
with allelic loss on chromosome 9. Oncogene (2003)
22:9217-24.
[23] Kumar, R; Angelini, S*; Czene, K*; Sauroja, I*; Hahka-
Kempinen, M*; Pyrhonen, S*; Hemminki, K. BRAF mutations in
metastatic melanomas: association with clinical outcome. Clinical
Cancer Res (2003) 9:3362-8.
[24] Shao, YH*; Försti, A; Egevad, L*; Anderson, LM*; Lindblad,
P*; Hemminki, K. VHL down-regulation and differential localization
as mechanisms in tumorigenesis. Kidney Internat (2003)
64:1671-4
[25] Sallmen, M*; Liesivuori, J*; Taskinen, H*; Lindbohm, ML*;
Anttila, A*; Aalto, L*; Hemminki, K. Time to pregnancy among
the wives of Finnish greenhouse workers. Scand J Work Environ
Health (2003) 29:85-93.
[26] Li, X*; Hemminki, K. Familial and second lung cancers: nation-wide
epidemiological study from Sweden. Lung Cancer
(2003) 39:255-63.
[27] Hemminki, K; Jiang, Y*; Steineck, G*. Skin cancer and non-
Hodgkin’s lymphoma as second malignancies: markers of impaired
immune function? Eur J Cancer (2003) 39:223-9.
[28] Hemminki, K; Li, X*. Time trends and occupational risk factors
for peritoneal mesothelioma in Sweden. J Occup Environ
Med (2003) 45:451-5.
[29] Hemminki, K; Li, X*. Time trends and occupational risk factors
for pleural mesothelioma in Sweden. J Occup Environ Med
(2003) 45:456-61.
[30] Hemminki, K; Li, X*. Mesothelioma is a killer of urban men in
Sweden. Int J Cancer (2003) 105:144-6.
[31] Hemminki, K; Zhang, H*; Czene, K*. Familial and attributable
risks in cutaneous melanoma: effects of proband and age. J Invest
Dermatol (2003) 120:217-23.
[32] Hemminki, K; Li, X*. Familial liver and gall bladder cancer: a
nationwide epidemiological study from Sweden. Gut (2003)
4:592-6.
[33] Hemminki, K; Zhang, H*; Czene, K*. Association of first ocular
melanoma with subsequent cutaneous melanoma: results from
the Swedish Family-Cancer Database. Int J Cancer (2003)
104:257-8.
[34] Czene, K*; Hemminki, K. Familial papillary renal cell tumors
and subsequent cancers: a nationwide epidemiological study
from Sweden. J Urol (2003) 169:1271-5.
[35] Hemminki, K; Zhang, H*; Czene, K*. Incidence trends and
familial risks in invasive and in situ cutaneous melanoma by sunexposed
body sites. Int J Cancer (2003) 104: 764-71.
[36] Czene, K*; Tiikkaja, S*; Hemminki, K. Cancer risks in hairdressers:
assessment of carcinogenicity of hair dyes and gels.
Int J Cancer (2003) 105:108-12.
[37] Hemminki, K; Li, X*. Finnish and Swedish genotypes and risk
of cancer in Sweden. Eur J Hum Genet (2003) 11:207-9.
[38] Hemminki, K; Zhang, H*; Czene, K*. Time trends and familial
risks in squamous cell carcinoma of the skin. Arch Dermatol
(2003) 139:885-9.
[39] Hemminki, K; Aaltonen, L*; Li, X*. Subsequent primary malignancies
after endometrial carcinoma and ovarian carcinoma.
Cancer (2003) 97:2432-9.
[40] Hemminki, K. Genetic and environmental factors in carcinogenesis.
In Handbook of Experimental Pharmacology, H. Vainio,
E. Hietanen (eds), Springer, Heidelberg, (2003) 13-24.
[41] Hemminki, K, Zhang, H*; Czene, K*. Familial invasive and in
situ squamous cell carcinoma of the skin. Br J Cancer (2003)
88:1375-80.
Abteilung C050
Molekular-Genetische Epidemiologie
[42] Hemminki, K; Granström, C*. Familial invasive and borderline
ovarian tumors by proband status, age and histology. Int J Cancer
(2003) 105:701-5.
[43] Hemminki, K; Zhang, H*; Czene, K*. Socioeconomic factors
in cancer in Sweden. Int J Cancer (2003) 105:692-700.
[44] Hemminki, K; Li, X*. Life style and cancer: effect of widowhood
and divorce. Cancer Epidemiol Biomarkers Prev. (2003)
12:899-904.
[45] Hemminki, K; Li, X*. Level of education and the risk of cancer
in Sweden. Cancer Epidemiol Biomarkers Prev. (2003)
12:796-802.
[46] Li, X*; Hemminki, K. Cancer risks in men who had children
with different partners from the Swedish Family-Cancer Database.
Eur J Cancer Prev (2003) 12:355-8.
[47] Hemminki, K; Li, X*. Familial risks in nervous system tumors.
Cancer Epidemiol Biomarkers Prev (2003) 12:1137-42.
[48] Hemminki, K; Granström, C*. Familial breast cancer: scope
for more susceptibility genes? Breast Cancer Res Treatment
(2003) 82:17-22.
[49] Hemminki, K; Granström, C*. Familial clustering of ovarian
and endometrial cancer. Eur J Cancer (2004) 40:90-5.
[50] Hemminki, K; Li, X*; Czene, K*. Familial risk of cancer: data
for clinical counseling and cancer genetics. Int J Cancer (2004)
108:109-14.
[51] Hemminki, K; Thilly, WG*. Implications of results of molecular
epidemiology on DNA adducts, their repair and mutations for
mechanisms of human cancer. IARC Sci Publ No 157 Lyon (2004)
S. 217-235.
[52] Hemminki, K; Boffetta, P. Multiple primary cancers as clues to
environmental and heritable causes of cancer and mechanisms of
carcinogenesis. IARC Sci Publ. No 157 Lyon (2004) S. 289-297
[53] Hemminki, K; Li, X*. Association of brain tumours with other
neoplasms in families. Eur J Cancer 2004, im Druck.
[54] Hemminki, K; Li, X*; Czene, K*. Familial risk of urological cancer:
data for clinical counseling. World J Urol (2004) 6:377-81.
[55] Hemminki, K; Li, X*. Familial risks of cancer as a guide to
gene identification and mode of inheritance. Int J Cancer (2004)
110:291-4.
[56] Lorenzo, BJ; Hemminki, K. Familial association of histology
specific breast cancers with cancers at other sites. Int J Cancer,
im Druck.
[57] Hemminki, K; Li, X*. Familial renal cell cancer appears to
have a recessive component. J Med Genet (2004) 41(5).
[58] Hemminki, K; Rawal, R; Chen, B; Lorenzo, BJ. Genetic epidemiology
of cancer: from families to heritable genes. Int J Cancer
(2004) 111:944-950.
[59] Lorenzo, BJ; Rawal, R; Hemminki, K. Association of histology
specific ovarian cancers with other cancer. Cancer (2004) im
Druck.
[60] Li, X*; Hemminki, K. Inherited predisposition to early onset
lung cancer according to histological type. Int J Cancer (2004)
112:451-457.
[61] Hemminki, K; Czene, K*. Time trends in squamous cell carcinoma
of the skin-reply. Arch Dermatol. (2004) im Druck.
[62] Lorenzo, BJ; Büchner, FL*; Hemminki, K. Familial risk of endometrial
cancer excluding families fulfilling Amsterdam criteria I-
II and the Bethesda guidelines for HNPCC. Ann Oncol. (2004) im
Druck.
[63] Hemminki, K; Li, X*. Familial risks in testicular cancers as
clues to heritable and environmental aetiology. Br J Cancer
(2004) 90:1765-1770.
[64] Hemminki, K; Li, X*. Familial risks for renal cell carcinoma with
evidence on recessive heritable effects. Kidney Internat (2004)
im Druck.
[65] Kumar, R; Angelini, S*; Snellman, E*; Hemminki, K. BRAF
mutations are commen somatic events in melanocytic nevi. J.
Inv. Derm. (2004) 122:342-8.
DKFZ 2004: Wissenschaftlicher Ergebnisbericht 2002 - 2003